Addus HomeCare Co. (NASDAQ:ADUS) Shares Acquired by Amalgamated Bank

Amalgamated Bank lifted its stake in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 8.4% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 5,330 shares of the company’s stock after purchasing an additional 412 shares during the quarter. Amalgamated Bank’s holdings in Addus HomeCare were worth $619,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently made changes to their positions in the company. Dimensional Fund Advisors LP raised its stake in Addus HomeCare by 0.8% in the 2nd quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock worth $82,930,000 after acquiring an additional 5,421 shares during the last quarter. American Century Companies Inc. raised its stake in shares of Addus HomeCare by 90.6% in the second quarter. American Century Companies Inc. now owns 18,393 shares of the company’s stock worth $2,136,000 after purchasing an additional 8,743 shares during the last quarter. Van Hulzen Asset Management LLC lifted its holdings in shares of Addus HomeCare by 5.4% during the second quarter. Van Hulzen Asset Management LLC now owns 30,175 shares of the company’s stock worth $3,504,000 after purchasing an additional 1,551 shares during the period. Texas Permanent School Fund Corp lifted its holdings in shares of Addus HomeCare by 0.6% during the second quarter. Texas Permanent School Fund Corp now owns 14,089 shares of the company’s stock worth $1,636,000 after purchasing an additional 82 shares during the period. Finally, Choreo LLC purchased a new stake in Addus HomeCare in the second quarter valued at approximately $340,000. 95.35% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, EVP Michael D. Wattenbarger sold 21,917 shares of the business’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the completion of the sale, the executive vice president now owns 7,215 shares of the company’s stock, valued at $961,687.35. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Addus HomeCare news, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total transaction of $63,750.00. Following the sale, the director now owns 3,366 shares of the company’s stock, valued at approximately $429,165. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the completion of the sale, the executive vice president now owns 7,215 shares of the company’s stock, valued at $961,687.35. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 22,917 shares of company stock worth $3,050,082. Company insiders own 4.60% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on ADUS. StockNews.com lowered shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Sunday, July 7th. Royal Bank of Canada reissued an “outperform” rating and set a $141.00 target price on shares of Addus HomeCare in a report on Tuesday, September 3rd. TD Cowen upped their price target on shares of Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a report on Thursday, August 8th. Oppenheimer lifted their price objective on Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research note on Monday, September 23rd. Finally, Macquarie assumed coverage on Addus HomeCare in a research note on Friday, June 28th. They issued an “outperform” rating and a $136.00 target price on the stock. One equities research analyst has rated the stock with a sell rating and eight have issued a buy rating to the company’s stock. Based on data from MarketBeat, Addus HomeCare has a consensus rating of “Moderate Buy” and a consensus target price of $128.29.

Addus HomeCare Stock Down 0.7 %

ADUS stock opened at $130.95 on Friday. Addus HomeCare Co. has a 52-week low of $78.35 and a 52-week high of $136.12. The firm has a market cap of $2.37 billion, a P/E ratio of 32.49, a PEG ratio of 2.40 and a beta of 1.04. The company’s 50-day simple moving average is $128.25 and its 200-day simple moving average is $115.31.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, August 5th. The company reported $1.35 earnings per share for the quarter, topping the consensus estimate of $1.21 by $0.14. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. The business had revenue of $286.90 million during the quarter, compared to the consensus estimate of $284.90 million. During the same period in the prior year, the company posted $0.94 EPS. The business’s quarterly revenue was up 10.4% on a year-over-year basis. On average, analysts anticipate that Addus HomeCare Co. will post 4.58 earnings per share for the current fiscal year.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.